IBD相关脊柱关节炎的肠上皮损伤、微生物易位与免疫激活
该研究探讨IBD相关脊柱关节炎(SpA-IBD)患者肠道细菌浸润与上皮损伤,以及微生物易位与免疫激活的关系。结果显示SpA-IBD较IBD患者回肠样本存在细菌浸润、上皮损伤和紧密连接蛋白下调,血清I-FABP、LPS、sCD14升高,且LPS与sCD14协同下调成骨细胞硬化蛋白表达。
要点
- SpA-IBD患者回肠存在细菌浸润、上皮损伤及紧密连接蛋白下调。
- SpA-IBD患者血清I-FABP、LPS、sCD14升高,sCD14与硬化蛋白及抗硬化蛋白IgG相关。
- 体外LPS与sCD14协同作用可下调成骨细胞硬化蛋白表达。
核心结论
- SpA-IBD患者以肠上皮损伤、微生物产物入血、免疫系统激活及特定可溶性生物标志物升高为特征。
- 肠道菌群失调可能参与SpA-IBD的发病机制。
研究设计与样本
- 研究比较SpA-IBD与IBD患者回肠样本的紧密连接蛋白occludin和claudin-1/-4及细菌,采用实时PCR和免疫组化检测。
- 用ELISA检测血清I-FABP、LPS、sCD14、硬化蛋白及抗硬化蛋白IgG,用流式细胞术检测外周单个核细胞。
- 体外用LPS和sCD14刺激人成骨细胞系。
主要发现
- 与IBD相比,SpA-IBD患者回肠样本显示细菌浸润、上皮损伤和紧密连接蛋白下调。
- SpA-IBD患者血清I-FABP、LPS、sCD14水平更高,sCD14与硬化蛋白及抗硬化蛋白IgG相关。
- SpA-IBD患者CD80+/CD163+单个核细胞更高、CD14+单个核细胞更低。
- 体外实验显示仅LPS与sCD14协同作用可下调成骨细胞硬化蛋白表达。
临床怎么用
- I-FABP、LPS、sCD14等生物标志物有望用于IBD患者的随访和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Gut microbiota has been widely reported to be involved in systemic inflammation through microbial translocation and T cell activation in several diseases. In this work we aimed to investigate bacterial infiltration and epithelial impairment in the gut of patients with IBD-associated SpA (SpA-IBD), as well as the relationship of microbial translocation with immune system activation and their putative role in the pathogenesis of joint inflammation in IBD patients. METHODS: Tight-junction proteins (TJPs) occludin and claudin-1/-4 and bacteria were assessed by real-time PCR analysis and immunohistochemical staining of the ileum. Intestinal fatty acid binding protein (I-FABP), lipopolysaccharides (LPS), soluble CD14 (sCD14), sclerostin and anti-sclerostin antibodies (anti-sclerostin-IgG) were assayed with ELISAs and peripheral mononuclear blood cells with flow cytometry. LPS and sCD14 were used in vitro to stimulate a human osteoblast cell line. RESULTS: Compared with IBD, ileal samples from SpA-IBD patients showed bacterial infiltration, epithelial damage and downregulation of TJPs. In sera, they showed higher serum levels of I-FABP, LPS, sCD14 (the latter correlating with sclerostin and anti-sclerostin-IgG) and higher CD80+/CD163+ and lower CD14+ mononuclear cells. In vitro experiments demonstrated that only the LPS and sCD14 synergic action downregulates sclerostin expression in osteoblast cells. CONCLUSION: SpA-IBD patients are characterized by gut epithelium impairment with consequent translocation of microbial products into the bloodstream, immune system activation and an increase of specific soluble biomarkers. These findings suggest that gut dysbiosis could be involved in the pathogenesis of SpA-IBD and it could hopefully prompt the use of these biomarkers in the follow-up and management of IBD patients.
引用
- Luchetti MM, Ciccia F, Avellini C, et al. Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. Rheumatology (Oxford). 2021. PMID: 32442267. doi:10.1093/rheumatology/keaa164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。